Harvard Bioscience
HBIO
84 hedge funds and large institutions have $129M invested in Harvard Bioscience in 2015 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 28 increasing their positions, 25 reducing their positions, and 13 closing their positions.
38% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 13
12% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 25
12% more capital invested
Capital invested by funds: $116M → $129M (+$13.5M)
6% more funds holding
Funds holding: 79 → 84 (+5)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $54K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.42M |
| 2 |
RA
Royce & Associates
New York
|
+$3.05M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.61M |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.46M |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$1.13M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PM
Penbrook Management
New York
|
-$1.62M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
-$1.57M |
| 3 |
BG
BlackRock Group
London,
United Kingdom
|
-$538K |
| 4 |
FA
Friess Associates
Greenville,
Delaware
|
-$524K |
| 5 |
PSC
Piper Sandler & Co
Minneapolis,
Minnesota
|
-$437K |
HBIO Hedge Fund Activity: Q2 2015 in Review
84 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Harvard Bioscience (HBIO) for Q2 2015, worth a combined $129M — up 12% from $116M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new HBIO positions and 13 closed out — a net gain of 5 holders — while 28 added to existing stakes and 25 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $4.42M. The largest seller was Penbrook Management, cutting an estimated $1.62M.
- 84 institutional investors held Harvard Bioscience (HBIO) as of Q2 2015, up from 79 in Q1 2015.
- Funds reported $129M of Harvard Bioscience stock for Q2 2015, up 12% quarter-over-quarter.
- 18 funds opened new Harvard Bioscience positions in Q2 2015 and 13 closed out, a net change of +5 holders.
- The largest Harvard Bioscience buyer in Q2 2015 was BlackRock Fund Advisors, an estimated $4.42M added.
- The largest Harvard Bioscience seller in Q2 2015 was Penbrook Management, an estimated $1.62M sold.
Based on aggregated 13F filings for Q2 2015.